rs876661127
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PVS1_Moderate
The NM_000179.3(MSH6):c.4016_4017dupCT(p.Ser1340LeufsTer7) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000193 in 1,602,500 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. S1340S) has been classified as Likely benign.
Frequency
Consequence
NM_000179.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- intellectual developmental disorder with dysmorphic facies and behavioral abnormalitiesInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MSH6 | NM_000179.3 | c.4016_4017dupCT | p.Ser1340LeufsTer7 | frameshift_variant | Exon 10 of 10 | ENST00000234420.11 | NP_000170.1 | |
| FBXO11 | NM_001190274.2 | c.*1324_*1325dupAG | downstream_gene_variant | ENST00000403359.8 | NP_001177203.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MSH6 | ENST00000234420.11 | c.4016_4017dupCT | p.Ser1340LeufsTer7 | frameshift_variant | Exon 10 of 10 | 1 | NM_000179.3 | ENSP00000234420.5 | ||
| FBXO11 | ENST00000403359.8 | c.*1324_*1325dupAG | downstream_gene_variant | 1 | NM_001190274.2 | ENSP00000384823.4 |
Frequencies
GnomAD3 genomes AF: 0.0000134 AC: 2AN: 148958Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.00000403 AC: 1AN: 247898 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000200 AC: 29AN: 1453542Hom.: 0 Cov.: 32 AF XY: 0.0000207 AC XY: 15AN XY: 722896 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000134 AC: 2AN: 148958Hom.: 0 Cov.: 31 AF XY: 0.0000276 AC XY: 2AN XY: 72460 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:2
The c.4016_4017dupCT variant, located in coding exon 10 of the MSH6 gene, results from a duplication of CT at nucleotide position 4016, causing a translational frameshift with a predicted alternate stop codon (p.S1340Lfs*7). This alteration occurs at the 3' terminus of theMSH6 gene, is not expected to trigger nonsense-mediated mRNAdecay, and only impacts the last 21 amino acids of the protein. The exact functional effect of this alteration is unknown. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
This variant inserts 2 nucleotides in exon 10 of the MSH6 gene, creating a frameshift and premature translation stop signal in the last coding exon. This variant is not expected to trigger nonsense-mediated decay. This variant changes the 21 C-terminal amino acids in the reference MSH6 protein. To our knowledge, this variant has not been reported in individuals affected with MSH6-related disorders in the literature. This variant has been identified in 3/277834 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of MSH6 function is a known mechanism of disease (clinicalgenome.org). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Lynch syndrome Uncertain:1
This variant inserts 2 nucleotides in exon 10 of the MSH6 gene, creating a frameshift and premature translation stop signal in the last coding exon. This variant is not expected to trigger nonsense-mediated decay. This variant changes the 21 C-terminal amino acids in the reference MSH6 protein. To our knowledge, this variant has not been reported in individuals affected with MSH6-related disorders in the literature. This variant has been identified in 3/277834 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of MSH6 function is a known mechanism of disease (clinicalgenome.org). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
Frameshift variant predicted to result in protein truncation as the last 21 amino acids are replaced with 6 different amino acids, although loss-of-function variants have not been reported downstream of this position in the protein; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 12019211, 17531815, 21120944, 30787465) -
Hereditary nonpolyposis colorectal neoplasms Uncertain:1
This sequence change creates a premature translational stop signal (p.Ser1340Leufs*7) in the MSH6 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 21 amino acid(s) of the MSH6 protein. This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with MSH6-related conditions. ClinVar contains an entry for this variant (Variation ID: 234626). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Endometrial carcinoma Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at